Company

Wheeler Bio

Wheeler Bio provides biomanufacturing and development services for preclinical drug programs.

About

Established in 2020 and based in Oklahoma, US, Wheeler Bio provides biomanufacturing and discovery-to-IND services through its Portable CMC platform. Its services are designed to support preclinical contract research organizations and contract development and manufacturing partners. In January 2022, the company raised USD 14 million in seed funding co-led by Alloy Therapeutics, Inc. and Echo Investment Capital, with participation from FPG Inc. and Presbyterian Health Foundation.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in